Evidence map›Paper›PMID 31528854›Full record

ReviewEuropean journal of obstetrics & gynecology and reproductive biology: X2019

Vaginal endometrial stromal sarcoma: A literature review.

Hongwen Wu, Yi Luo, Nanlin Yin, Wenwu Gui, Yi Cao

Open access · goldAbstract readReview
In one paragraph

Review in European journal of obstetrics & gynecology and reproductive biology: X, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. [Expressions of HELQ and RAD51C in endometrial stromal sarcoma and their clinical significance].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  3. Vaginal Endometrial Stroma Sarcoma: A Case Report of A Rare Disease.Journal of the West African College of Surgeons
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hongwen WuReproductive Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yi LuoDepartment of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing China.
Nanlin YinReproductive Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wenwu GuiReproductive Medical Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yi CaoDepartment of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing China.
Chongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaginal endometrial stromal sarcoma (VESS) is a rare disease. To the best of our knowledge, there have only been a few reported cases in the literature. Therefore, we conducted a literature review to obtain specific knowledge of this disease. Thirteen cases of VESS were found by searching the Medline and EMBASE databases in the English language. The mechanism of VESS may be associated with endometriosis, and its diagnosis largely depends on pathological examination because it has no typical symptoms. Treatment of VESS incorporates surgery, chemotherapy, radiotherapy, and hormonal therapy. Some novel drugs targeting its mechanism may become alternative therapies. Its prognostic factors may include tumor stage and the expression of hormonal receptors.

Indexed as

Endometrial stromal sarcomaMalignant transformation of endometriosisVaginal endometrial stromal sarcomaVaginal sarcoma

Identifiers

PMID31528854
PMCPMC6742903
OpenAlexW2970706871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.